<!DOCTYPE html>
<html>
<head>
<meta charset = "utf-8">
<title>710 結締組織瀰漫性疾病</title>
<style type = "text/css">
table{width: 1100px; border-collapse: collapse; background-color: lightblue; font-family: sans-serif; margin:0px auto;}
table, td, th { border: 1px solid black; padding: 4px; }
th { text-align: left; color: white; background-color: darkblue; }
tr.oddrow { background-color: white; }
</style>
</head>
<body>
<table>
<caption>710-結締組織瀰漫性疾病</caption>
<thead><tr><th>ICD 710</th>
<th>Gene/Locus name</th>
<th>Location</th>
<th>Gene/Locus</th>
<th>Gene/Locus MIM number</th>
<th>Phenotype MIM number</th>
<th>Match in DOID</th>
<th>Match in Orphanet</th>
<th>Match distinct gene</th>
</tr>
</thead>
<tbody>
<tr class='oddrow'><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 13</td><td>6q23</td><td>SLEB13</td><td><a href="https://www.omim.org/entry/612378?search=612378" target="_blank">612378</a></td><td><a href="https://www.omim.org/entry/612378?search=612378" target="_blank">612378</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Cytotoxic T-lymphocyte-associated serine esterase-4</td><td>2q33.2</td><td>CTLA4, IDDM12, CELIAC3, ALPS5</td><td><a href="https://www.omim.org/entry/123890?search=123890" target="_blank">123890</a></td><td><a href="https://www.omim.org/entry/152700?search=152700" target="_blank">152700</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Protein tyrosine phosphatase, nonreceptor-type 22</td><td>1p13.2</td><td>PTPN22, PEP, PTPN8, LYP</td><td><a href="https://www.omim.org/entry/600716?search=600716" target="_blank">600716</a></td><td><a href="https://www.omim.org/entry/152700?search=152700" target="_blank">152700</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Fc fragment of IgG, low affinity IIa, receptor for (CD32)</td><td>1q23.3</td><td>FCGR2A, IGFR2, CD32</td><td><a href="https://www.omim.org/entry/146790?search=146790" target="_blank">146790</a></td><td><a href="https://www.omim.org/entry/152700?search=152700" target="_blank">152700</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Fc fragment of IgG, low affinity IIb, receptor for</td><td>1q23.3</td><td>FCGR2B, CD32</td><td><a href="https://www.omim.org/entry/604590?search=604590" target="_blank">604590</a></td><td><a href="https://www.omim.org/entry/152700?search=152700" target="_blank">152700</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Deoxyribonuclease I</td><td>16p13.3</td><td>DNASE1, DNL1</td><td><a href="https://www.omim.org/entry/125505?search=125505" target="_blank">125505</a></td><td><a href="https://www.omim.org/entry/152700?search=152700" target="_blank">152700</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>710</td><td>3' repair exonuclease 1</td><td>3p21.31</td><td>TREX1, AGS1, CRV, HERNS</td><td><a href="https://www.omim.org/entry/606609?search=606609" target="_blank">606609</a></td><td><a href="https://www.omim.org/entry/152700?search=152700" target="_blank">152700</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Deoxyribonuclease I-like 3</td><td>3p14.3</td><td>DNASE1L3, SLEB16</td><td><a href="https://www.omim.org/entry/602244?search=602244" target="_blank">602244</a></td><td><a href="https://www.omim.org/entry/614420?search=614420" target="_blank">614420</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 8</td><td>20q13</td><td>SLEB8</td><td><a href="https://www.omim.org/entry/610066?search=610066" target="_blank">610066</a></td><td><a href="https://www.omim.org/entry/610066?search=610066" target="_blank">610066</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 4</td><td>12q24</td><td>SLEB4</td><td><a href="https://www.omim.org/entry/608437?search=608437" target="_blank">608437</a></td><td><a href="https://www.omim.org/entry/608437?search=608437" target="_blank">608437</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 15</td><td>Xq28</td><td>SLEB15</td><td><a href="https://www.omim.org/entry/300809?search=300809" target="_blank">300809</a></td><td><a href="https://www.omim.org/entry/300809?search=300809" target="_blank">300809</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td></td><td></td><td></td><td><a href="https://www.omim.org/entry/?search=" target="_blank"></a></td><td><a href="https://www.omim.org/entry/181750?search=181750" target="_blank">181750</a></td><td>YES</td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>710</td><td></td><td></td><td></td><td><a href="https://www.omim.org/entry/?search=" target="_blank"></a></td><td><a href="https://www.omim.org/entry/270150?search=270150" target="_blank">270150</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 5</td><td>13q32</td><td>SLEB5</td><td><a href="https://www.omim.org/entry/609903?search=609903" target="_blank">609903</a></td><td><a href="https://www.omim.org/entry/609903?search=609903" target="_blank">609903</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 14</td><td>1q21-q23</td><td>SLEB14</td><td><a href="https://www.omim.org/entry/613145?search=613145" target="_blank">613145</a></td><td><a href="https://www.omim.org/entry/613145?search=613145" target="_blank">613145</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 12</td><td>8p23.1</td><td>SLEB12</td><td><a href="https://www.omim.org/entry/612254?search=612254" target="_blank">612254</a></td><td><a href="https://www.omim.org/entry/612254?search=612254" target="_blank">612254</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Integrin, alpha-M (complement component receptor-3, alpha; antigen CD11B (p170); macrophage antigen, alpha polypeptide)</td><td>16p11.2</td><td>ITGAM, CR3A, CD11B, MAC1A, SLEB6</td><td><a href="https://www.omim.org/entry/120980?search=120980" target="_blank">120980</a></td><td><a href="https://www.omim.org/entry/609939?search=609939" target="_blank">609939</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Signal transducer and activator of transcription-3 (acute-phase response factor)</td><td>17q21.2</td><td>STAT3, APRF, HIES, ADMIO1</td><td><a href="https://www.omim.org/entry/102582?search=102582" target="_blank">102582</a></td><td><a href="https://www.omim.org/entry/615952?search=615952" target="_blank">615952</a></td><td></td><td>YES</td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 7</td><td>20p12</td><td>SLEB7</td><td><a href="https://www.omim.org/entry/610065?search=610065" target="_blank">610065</a></td><td><a href="https://www.omim.org/entry/610065?search=610065" target="_blank">610065</a></td><td>YES</td><td></td><td></td></tr>
<tr><td>710</td><td>Systemic lupus erythematosus, susceptibility to, 3</td><td>4p16-p15.2</td><td>SLEB3</td><td><a href="https://www.omim.org/entry/605480?search=605480" target="_blank">605480</a></td><td><a href="https://www.omim.org/entry/605480?search=605480" target="_blank">605480</a></td><td>YES</td><td></td><td></td></tr>
<tr class='oddrow'><td>710</td><td>Transmembrane protein 173</td><td>5q31.2</td><td>TMEM173, STING, MPYS, SAVI</td><td><a href="https://www.omim.org/entry/612374?search=612374" target="_blank">612374</a></td><td><a href="https://www.omim.org/entry/615934?search=615934" target="_blank">615934</a></td><td></td><td>YES</td><td>TMEM173:FAM83C(chr20:35286917)</td></tr>
</tbody></table>
</body>
</html>
